• EPZ-6438: A Framework for EZH2 Dependency

  2026-10-01

  EPZ-6438 is an EZH2 inhibitor for dissecting PRC2-driven transcriptional repression across cancer models. This article presents an assay-centered framework for connecting H3K27me3 loss with cell-state changes, HPV biology, and translational limitations.

• Cediranib (AZD2171) in Angiogenesis Assays

  2026-10-01

  Cediranib (AZD2171) supports mechanism-first studies of VEGFR-driven angiogenesis, from target-proximal phosphorylation to endothelial phenotypes and tumor-cell response. This workflow pairs pathway readouts with separate growth-arrest and cell-death measurements, reducing the risk of mistaking reduced proliferation for cytotoxicity.

• Liproxstatin-1 for Ferroptosis Research

  2026-09-30

  Liproxstatin-1 provides a practical way to separate ferroptotic lipid damage from apoptosis, oxidative stress, and emerging metal-dependent death pathways. This workflow-focused guide shows how to use it in viability assays, BODIPY-based lipid peroxidation measurements, GPX4-deficient cell protection studies, and renal injury models.

• HyperScribe T7 High Yield Cy5 RNA Labeling Kit Guide

  2026-09-30

  Build tunable Cy5-labeled RNA probes for in situ hybridization and Northern blot workflows while balancing fluorescent nucleotide incorporation against transcription yield. The workflow also shows how these probes can support spatial studies inspired by recent cleavage-resistant TREM2 macrophage research without confusing analytical labeling with therapeutic mRNA delivery.

• VNERi and Diastolic Pressure in Septic Shock

  2026-09-29

  Goury et al. proposed VNERi, calculated as diastolic arterial pressure divided by norepinephrine dose and heart rate, as a bedside-derived marker of vascular responsiveness. In a post-hoc analysis of early septic shock, VNERi showed stronger associations with mortality and organ-support-free outcomes than DAP, DAP/HR, or MAP divided by norepinephrine dose, while remaining an exploratory rather than treatment-directing index.

• 7ACC2 for MCT1 and Tumor Immunometabolism

  2026-09-29

  7ACC2 is a potent monocarboxylate transporter 1 inhibitor for dissecting lactate uptake, pyruvate flux, and metabolic stress in cancer models. This workflow-focused guide connects transporter assays with tumor-associated macrophage readouts while clearly separating established product evidence from exploratory immunometabolic applications.

• TaqI Restriction Endonuclease: Practical Guide

  2026-09-28

  TaqI Restriction Endonuclease (SKU K3053) provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA at the 5′…T↓CGA…3′ site. It is intended for research workflows such as DNA mapping, cloning, and fragment analysis, not for diagnostic or medical use.

• EZ Cap™ Firefly Luciferase mRNA: Assay Guide

  2026-09-28

  Use a capped, polyadenylated luciferase transcript to compare productive mRNA delivery and translation—not just cellular uptake. This guide pairs practical reporter workflows with a formulation-aware interpretation of recent findings on cationic lipids in mRNA-LNPs.

• Endoglin EV Signaling Drives Astrocyte Reactivity in AD

  2026-09-27

  A 2025 study identifies brain endothelial endoglin as extracellular-vesicle cargo that can activate astrocytes through TGFBRI/Smad3 signaling in an Alzheimer’s disease mouse model. Endothelial ENG knockdown and antibody treatment reduced reactive astrocytes and neuroinflammation and improved cognitive performance, highlighting a vascular-to-glial pathway for further investigation.

• Gamithromycin PK/PD Workflows for Respiratory Pathogens

  2026-09-26

  Build more informative respiratory-pathogen assays by pairing Gamithromycin susceptibility testing with serum-aware PK/PD analysis. Piglet data show why matrix choice, AUC24h/MIC, and model-specific interpretation matter—without mistaking experimental dose predictions for clinical advice.

• Nerve-Dependent HDAC1 Control of Axolotl Regeneration

  2026-09-25

  The study links nerve input to HDAC1 elevation in the wound epidermis and shows that HDAC inhibition or denervation impairs blastema formation and limb regeneration in axolotls. Its experiments suggest that nerve-associated HDAC activity is an important part of the regenerative response, while leaving open which HDAC1-dependent targets directly drive blastema development.

• Dacomitinib (PF-00299804) Research Workflows

  2026-09-25

  Use Dacomitinib to investigate pan-HER signaling, durable target inhibition, and response differences across sensitive and resistant cancer models. This workflow pairs practical dose and readout selection with a cautious, testable framework for exploring how receptor signaling intersects with the mitochondrial ferroptosis biology described in colorectal cancer research.

• hiPSC Intestinal Organoids for Pharmacokinetic Studies

  2026-09-24

  Saito and colleagues describe a direct three-dimensional culture approach for generating expandable, cryopreservable intestinal organoids from human induced pluripotent stem cells. After transfer to monolayer culture, the organoids produce intestinal epithelial cells with mature cell types and measurable drug-metabolizing enzyme and transporter activities, offering a human-derived platform for pharmacokinetic research.

• Separating Growth Inhibition from Cancer Cell Killing

  2026-09-24

  Hannah Schwartz’s 2022 dissertation highlights that relative viability and fractional viability measure different aspects of anticancer drug response: a mixture of growth inhibition and cell death versus cell killing specifically. Its central practical implication is to select and interpret response metrics according to the biological question, and to consider how response timing can affect conclusions.

• DOTAP for Nucleic Acid Delivery Workflows

  2026-09-23

  Use DOTAP to build and optimize nucleic acid complexes for transient gene expression, RNA perturbation, and functional genomics assays. A glaucoma-focused study offers a useful experimental blueprint for pairing gene delivery with a defined biological question—while also showing why its specialized lipid formulation should not be assumed to be DOTAP.

8723 records 3/582 page Previous Next 12345 下5页 Last page